Con­sti­pa­tion drug mak­er Syn­er­gy looks to rene­go­ti­ate bloat­ed loan agree­ment — shares tum­ble

Grap­pling with the slow up­take of its con­sti­pa­tion drug Tru­lance, Syn­er­gy Phar­ma­ceu­ti­cals $SGYP has prac­ti­cal­ly thrown in the tow­el say­ing that it does not an­tic­i­pate …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER